Clinical Research Facility

Twin Falls, Idaho 83301

We've found

2 trials

at this facility

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Twin Falls, ID

Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Twin Falls, ID

Use our guide to learn which trials are right for you!